BRO vs EBS
Brown & Brown Inc (BRO) versus Emergent Biosolutions Inc (EBS) — a side-by-side from cached financials, not a winner call.
Brown & Brown Inc (BRO) is a insurance brokers company listed on US.
Emergent Biosolutions Inc (EBS) is a drug manufacturers - specialty & generic company listed on US.
Latest reported BRO revenue for 2024-12-31 was $4.80B. Net income was $1.00B. Revenue was up 12.9% from 2023-12-31 to 2024-12-31. BRO currently screens at market cap $35.56B and trailing P/E 30.0.
Latest reported EBS revenue for 2024-12-31 was $1.04B. Net income was -$190.6M. Revenue was down 0.5% from 2023-12-31 to 2024-12-31. EBS currently screens at market cap $416.4M.
BRO currently screens at market cap $35.56B and trailing P/E 30.0. EBS currently screens at market cap $416.4M.
Not investment advice. Open the BRO and EBS stock pages for the full models.
Not investment advice.